PRTC Stock Analysis: Buy, Sell, or Hold?
PRTC - PureTech Health plc American Depositary Shares
$17.42
0.34 (1.99%)
▲
5d:
-0.51%
30d:
-3.49%
90d:
-2.16%
BUY
MODERATE Confidence
Analysis Updated: May 20, 2026 12:00 AM ET
Earnings: Aug 27, 2026
Get Alerted When PRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PRTC shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: PRTC shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PRTC is currently trading at $17.42, which is considered fair relative to its 30-day fair value range of $16.97 to $17.61.
Technical Outlook: Technically, PRTC is showing sideways momentum. Immediate support is located at $16.73, while resistance sits at $18.61.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $46.00 (+164.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PRTC is showing sideways momentum. Immediate support is located at $16.73, while resistance sits at $18.61.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $46.00 (+164.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$16.97 -
$17.61
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 164.1% below Wall St target ($46.00)
Trading Range Analysis
30-Day Trading Range
$16.97 -
$17.61
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$16.73
Resistance Level
$18.61
Current Trend
Sideways
Technical data as of
May 20, 2026
Fundamental Context
Wall Street Target
$46.00
(+164.1%)
Revenue Growth (YoY)
-38.2%
Earnings Growth (YoY)
61.5%
Share & Embed Analysis
Last updated: June 15, 2026 4:11 PM ET
Data refreshes hourly during market hours. Next update: 5:11 PM
Data refreshes hourly during market hours. Next update: 5:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 62 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 57 HOLD |
